What is Castle Biosciences, Inc. Common Stock's Market Cap?

Castle Biosciences, Inc. Common Stock's Market Cap is $1.0B, based on as-reported figures from SEC (XBRL) filings.

What is Castle Biosciences, Inc. Common Stock's Enterprise Value?

Castle Biosciences, Inc. Common Stock's Enterprise Value is $764.0M, based on as-reported figures from SEC (XBRL) filings.

What is Castle Biosciences, Inc. Common Stock's Price / Sales?

Castle Biosciences, Inc. Common Stock's Price / Sales is 2.8×, based on as-reported figures from SEC (XBRL) filings.

What is Castle Biosciences, Inc. Common Stock's EV / Revenue?

Castle Biosciences, Inc. Common Stock's EV / Revenue is 2.1×, based on as-reported figures from SEC (XBRL) filings.

What is Castle Biosciences, Inc. Common Stock's EV / EBITDA?

Castle Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Castle Biosciences, Inc. Common Stock's Revenue (TTM)?

Castle Biosciences, Inc. Common Stock's Revenue (TTM) is $357.3M, based on as-reported figures from SEC (XBRL) filings.

What is Castle Biosciences, Inc. Common Stock's Net Income (TTM)?

Castle Biosciences, Inc. Common Stock's Net Income (TTM) is -$19.4M, based on as-reported figures from SEC (XBRL) filings.

What is Castle Biosciences, Inc. Common Stock's EBITDA?

Castle Biosciences, Inc. Common Stock's EBITDA is -$16.5M, based on as-reported figures from SEC (XBRL) filings.

What is Castle Biosciences, Inc. Common Stock's Diluted EPS (TTM)?

Castle Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -0.64, based on as-reported figures from SEC (XBRL) filings.

What is Castle Biosciences, Inc. Common Stock's EBITDA Margin?

Castle Biosciences, Inc. Common Stock's EBITDA Margin is -4.6%, based on as-reported figures from SEC (XBRL) filings.

Castle Biosciences, Inc. Common Stock (CSTL) Financial Statements

Castle Biosciences, Inc. Common Stock

SIC 8071 · SERVICES-MEDICAL LABORATORIES

FIGI BBG006YWVSS2

XNAS · usd

33.18▲ 0.42 (1.28%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close32.76

Day's Range32.28 – 33.58

52-Week Range17.72 – 44.29

Volume214.0K

Avg Volume447.9K

Share Statistics

Shares Outstanding

Employees883

ExchangeXNAS

Listed2019-07-25

Share count as of July 23, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Castle Biosciences, Inc. Common Stock (CSTL)

What is Castle Biosciences, Inc. Common Stock's Market Cap?: Castle Biosciences, Inc. Common Stock's Market Cap is $1.0B, based on as-reported figures from SEC (XBRL) filings.
What is Castle Biosciences, Inc. Common Stock's Enterprise Value?: Castle Biosciences, Inc. Common Stock's Enterprise Value is $764.0M, based on as-reported figures from SEC (XBRL) filings.
What is Castle Biosciences, Inc. Common Stock's Price / Sales?: Castle Biosciences, Inc. Common Stock's Price / Sales is 2.8×, based on as-reported figures from SEC (XBRL) filings.
What is Castle Biosciences, Inc. Common Stock's EV / Revenue?: Castle Biosciences, Inc. Common Stock's EV / Revenue is 2.1×, based on as-reported figures from SEC (XBRL) filings.
What is Castle Biosciences, Inc. Common Stock's EV / EBITDA?: Castle Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Castle Biosciences, Inc. Common Stock's Revenue (TTM)?: Castle Biosciences, Inc. Common Stock's Revenue (TTM) is $357.3M, based on as-reported figures from SEC (XBRL) filings.
What is Castle Biosciences, Inc. Common Stock's Net Income (TTM)?: Castle Biosciences, Inc. Common Stock's Net Income (TTM) is -$19.4M, based on as-reported figures from SEC (XBRL) filings.
What is Castle Biosciences, Inc. Common Stock's EBITDA?: Castle Biosciences, Inc. Common Stock's EBITDA is -$16.5M, based on as-reported figures from SEC (XBRL) filings.
What is Castle Biosciences, Inc. Common Stock's Diluted EPS (TTM)?: Castle Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -0.64, based on as-reported figures from SEC (XBRL) filings.
What is Castle Biosciences, Inc. Common Stock's EBITDA Margin?: Castle Biosciences, Inc. Common Stock's EBITDA Margin is -4.6%, based on as-reported figures from SEC (XBRL) filings.